Navigation Links
InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
Date:12/3/2008

Cellastim, an animal-free recombinant albumin product manufactured by InVitria, can outperform animal and human derived serum in CHO cell culture.

Fort Collins, CO (PRWEB) December 3, 2008 -- Cellastim has proven to be a robust replacement for serum derived albumin in CHO media and can improve both the growth kinetics and productivity of CHO cell lines across a variety of chemically defined media.

Studies support InVitria's claim that its Cellastim Cellastim outperforms other chemically defined cell culture ingredients and can be used by the biopharmaceutical, mammalian cell culture, stem cell and regenerative medicine industries as a supplement for cell culture media.

Cellastim is a defined supplement that can enhance performance of chemically defined media. One study revealed that Cellastim outperformed plasma-derived human serum albumin with a 50% average increase in productivity in several chemically defined cell culture media.

"InVitria's Cellastim helps optimize cell culture media performance safely and effectively," said InVitria President Scott Deeter. "As a regulatory friendly product, Cellastim can provide researchers an option to free their cells from the risk of potentially harmful contaminants, while simultaneously enhancing cell growth and productivity."

The conversion from serum supplemented media to serum-free media for production of biopharmaceuticals in CHO cells is essential for the elimination of all animal components in the culturing media. The addition of InVitria's Cellastim offers optimal defined quality and safety for the production of biopharmaceuticals in CHO cells.

About InVitria:
InVitria has developed defined and animal-free cell culture media components that enhance cell growth, productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Cellastim is an animal free component used to enhance cell growth and productivity in cell culture media.

For more information about InVitria's products or to place an order, please contact InVitria's sales and marketing team by e-mail or phone.

E-mail: info (at) InVitria.com         
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/CHOCellCulture/Cellastim/prweb1702944.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Internet Service Delivers Relief to Families of Those in Long-Term Care
2. New Software Streamlines Interface Management, Delivers More System Security and Greater IT Control
3. Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM)
4. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
5. Decision Intelligence Delivers Marketing Contact Optimization Solutions
6. Illinois Commerce Commission Delivers $207 Million Ameren Rate Hike
7. Pennsylvania Commission for Women Delivers First Womens Wellness Guide Kiosk to Allegheny County Jail
8. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
9. Specialty Renal Pharmacy Delivers One Millionth Prescription
10. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
11. New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Dr. Andrew Lian-Jie Li ... trained Mohs and cosmetic surgeon. After extensive dermatology research training at the National ... in internal medicine at the Emory University and dermatology training at the University ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. ... a modern CTMS workflow designed to seamlessly integrate and streamline the way researchers ... a single page, maximizing usability and improving efficiency significantly for users – a ...
(Date:1/19/2017)... Antonio, Texas (PRWEB) , ... January 19, 2017 , ... ... the GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship ... accounts. The competition begins Feb. 1, and the deadline is May 31, with the ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite Ergonomics ... , The Tranquility privacy panel system was designed to deliver the ideal ... help reduce noise and provide the visual privacy required to maintain concentration levels ...
(Date:1/19/2017)... Pittsburgh, PA (PRWEB) , ... January 19, 2017 , ... ... the experience of patients who seek access to the Network’s programs and services in ... requesting primary or specialty care appointments will be offered one for that same afternoon. ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and PUNE, India , January ... by Allied Market Research, titled, "Breast Imaging Technologies Market by ... the global breast imaging technologies market size was valued at ... million by 2022, growing at a CAGR of 8.4% from ... Europe together accounted for over three-fourths ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
(Date:1/18/2017)... de 2017  Hoy, en el Foro Económico Mundial, ... global para avanzar el acceso a la prevención de ... renta baja y baja-media (LICs y LMICs). ... particularmente en países de renta baja y media, donde ... muertes relacionadas con NCD. El objetivo de Access Accelerated, ...
Breaking Medicine Technology: